← Back to Analyst Consensus 
CNSP Buy
CNS Pharmaceuticals, Inc.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 12, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 12, 2025 | Maxim Group | upgrade | Hold → Buy | $20 | 42% |
| Mar 25, 2025 | Maxim Group | downgrade | Buy → Hold | $0 | 42% |
Price Target Trend
Apr 21, 2026 Latest: $10 Oct 24, 2026
EPS Estimates
+1q $-0.27
Lo: $-0.27 Hi: $-0.27
1 analysts +1y $-1.66
Lo: $-1.66 Hi: $-1.66
1 analysts ▲1
0y $-1.65
Lo: $-1.65 Hi: $-1.65
1 analysts ▲1
0q $-0.27
Lo: $-0.27 Hi: $-0.27
1 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days